• Policy
• No companies have won suits on Gov's price cut dispositions
• by Lee, Hye-Kyung Nov 16, 2021 05:53am

• Company
• Drug price negotiations for Xospata began
• by Eo, Yun-Ho Nov 16, 2021 05:53am

• Policy
• Chong Kun Dang is approved for its Jardiance Duo latecomer
• by Lee, Tak-Sun Nov 16, 2021 05:52am

• Company
• Somavert can be prescribed at general hospitals
• by Eo, Yun-Ho Nov 16, 2021 05:52am

• Company
• Sales of Arcoxia (Etoricoxib) are sluggish
• by Kim, Jin-Gu Nov 16, 2021 05:52am

• Company
• The price reduction of PE waiver drugs
• by Eo, Yun-Ho Nov 15, 2021 06:29pm

• Company
• Will sales of flu treatments be recovered?
• by Chon, Seung-Hyun Nov 15, 2021 05:56pm

• Opinion
• [Reporter’s View] On HIRA's price cuts for PE waiver drugs
• by Eo, Yun-Ho Nov 15, 2021 05:56am

• Company
• K-COVID-19 vaccine developers will ‘power through till end'
• by Kim, Jin-Gu Nov 15, 2021 05:56am

• Policy
• Rx drugs,allowed according to CTD starting from next year
• by Lee, Tak-Sun Nov 15, 2021 05:56am